Hyperandrogenemia	B:C1299574
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
:	O
prevalence	O
,	O
characteristics	O
and	O
association	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

Hyperandrogenemia	O
in	O
women	B:C0043210
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
:	O
prevalence	O
,	O
characteristics	O
and	O
association	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

Hyperandrogenemia	O
in	O
women	O
with	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
:	O
prevalence	O
,	O
characteristics	O
and	O
association	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

Hyperandrogenemia	O
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
:	O
prevalence	O
,	O
characteristics	O
and	O
association	O
with	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
.	O

Hyperandrogenemia	B:C1299574
is	O
one	O
of	O
the	O
major	O
diagnostic	O
features	O
for	O
the	O
diagnosis	O
of	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
(	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
)	O
.	O

Hyperandrogenemia	O
is	O
one	O
of	O
the	O
major	O
diagnostic	O
features	O
for	O
the	O
diagnosis	B:C0011900
of	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
(	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
)	O
.	O

Hyperandrogenemia	O
is	O
one	O
of	O
the	O
major	O
diagnostic	O
features	O
for	O
the	O
diagnosis	O
of	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
(	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
)	O
.	O

Hyperandrogenemia	O
is	O
one	O
of	O
the	O
major	O
diagnostic	O
features	O
for	O
the	O
diagnosis	O
of	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
(	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	B:C1299574
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	B:C0043210
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	O
with	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	B:C0150312
of	O
hyperandrogenemia	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyperandrogenemia	O
in	O
women	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
according	O
to	O
the	O
presence	O
of	O
hyperandrogenemia	B:C1299574
.	O

We	O
studied	O
266	O
women	B:C0043210
diagnosed	O
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
.	O

We	O
studied	O
266	O
women	O
diagnosed	B:C0011900
with	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
.	O

We	O
studied	O
266	O
women	O
diagnosed	O
with	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
.	O

Hyperandrogenemia	B:C1299574
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	B:C0039601
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	B:C0039601
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	B:C0443483
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	B:C0443483
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	B:C4284099
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	B:C4284099
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	O
.	O

Hyperandrogenemia	O
was	O
defined	O
by	O
testosterone	O
(	O
testosterone	O
)	O
and	O
/	O
or	O
free	O
testosterone	I:C0443483
(	O
free	O
testosterone	I:C0443483
)	O
and	O
/	O
or	O
∆4	O
androstenedione	I:C4284099
(	O
Δ4	O
-	I:C4284099
A	I:C4284099
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	B:C0019932
.	O

Patients	O
were	O
stratified	O
in	O
two	O
groups	B:C1257890
according	O
to	O
a	O
body	O
mass	I:C1305855
index	I:C1305855
threshold	O
of	O
25	O
kg	O
/	O
m2	O
.	O

Patients	O
were	O
stratified	O
in	O
two	O
groups	O
according	O
to	O
a	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
threshold	O
of	O
25	O
kg	O
/	O
m2	O
.	O

Hyperandrogenemia	B:C1299574
was	O
present	O
in	O
78.2	O
%	O
of	O
the	O
patients	O
.	O

Hyperandrogenemia	O
was	O
present	B:C0150312
in	O
78.2	O
%	O
of	O
the	O
patients	O
.	O

Elevated	O
levels	O
of	O
testosterone	B:C0039601
were	O
found	O
in	O
58.4	O
%	O
,	O
while	O
elevated	O
levels	O
of	O
free	O
testosterone	I:C0443483
and	O
Δ4	O
-	I:C4284099
A	I:C4284099
were	O
found	O
in	O
42.5	O
%	O
and	O
34.1	O
%	O
of	O
patients	O
.	O

Elevated	O
levels	O
of	O
testosterone	O
were	O
found	O
in	O
58.4	O
%	O
,	O
while	O
elevated	O
levels	O
of	O
free	B:C0443483
testosterone	I:C0443483
and	O
Δ4	O
-	I:C4284099
A	I:C4284099
were	O
found	O
in	O
42.5	O
%	O
and	O
34.1	O
%	O
of	O
patients	O
.	O

Elevated	O
levels	O
of	O
testosterone	O
were	O
found	O
in	O
58.4	O
%	O
,	O
while	O
elevated	O
levels	O
of	O
free	O
testosterone	I:C0443483
and	O
Δ4	B:C4284099
-	I:C4284099
A	I:C4284099
were	O
found	O
in	O
42.5	O
%	O
and	O
34.1	O
%	O
of	O
patients	O
.	O

In	O
normal	B:C2712185
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	B:C0043210
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	B:C1299574
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	B:C0562350
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	B:C3639411
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	B:C0039601
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	B:C0443483
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	B:C4284099
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	B:C0045010
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	B:C0045010
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	B:C0057277
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	B:C0057277
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	B:C0023516
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	B:C0023516
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	B:C0027950
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	B:C0043210
without	O
hyperandrogenemia	O
.	O

In	O
normal	O
weight	I:C2712185
women	O
(	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/	O
m2	O
)	O
with	O
hyperandrogenemia	O
lower	O
values	O
of	O
hip	O
circumference	I:C0562350
and	O
HOMA	O
-IR	I:C3639411
and	O
increased	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
hydroxyprogesterone	I:C0045010
(	O
17	O
-	I:C0045010
OHP	I:C0045010
)	O
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
(	O
dehydroepiandrosterone	O
sulfate	I:C0057277
)	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
(	O
white	O
blood	I:C0023516
cells	I:C0023516
)	O
and	O
neutrophils	O
were	O
observed	O
compared	O
to	O
women	O
without	O
hyperandrogenemia	B:C1299574
.	O

Also	O
,	O
in	O
overweight	B:C0497406
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	B:C0043210
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	B:C0039601
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	B:C0443483
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	B:C4284099
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	B:C0045010
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	B:C0057277
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	B:C0020268
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	B:C0202230
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	B:C0043210
without	O
hyperandrogenemia	O
.	O

Also	O
,	O
in	O
overweight	O
women	O
higher	O
levels	O
of	O
testosterone	O
,	O
free	O
testosterone	I:C0443483
,	O
Δ4	O
-	I:C4284099
A	I:C4284099
,	O
17	O
-	I:C0045010
OHP	I:C0045010
,	O
dehydroepiandrosterone	O
sulfate	I:C0057277
and	O
cortisol	O
were	O
measured	O
,	O
while	O
lower	O
thyroid	O
-	I:C0202230
stimulating	I:C0202230
hormone	I:C0202230
(	I:C0202230
TSH	I:C0202230
)	I:C0202230
levels	I:C0202230
were	O
comparable	O
to	O
women	O
without	O
hyperandrogenemia	B:C1299574
.	O

This	O
study	O
showed	O
high	O
prevalence	O
of	O
hyperandrogenemia	B:C1299574
in	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
women	O
.	O

This	O
study	O
showed	O
high	O
prevalence	O
of	O
hyperandrogenemia	O
in	O
polycystic	B:C0032460
ovary	I:C0032460
syndrome	I:C0032460
women	O
.	O

This	O
study	O
showed	O
high	O
prevalence	O
of	O
hyperandrogenemia	O
in	O
polycystic	O
ovary	I:C0032460
syndrome	I:C0032460
women	B:C0043210
.	O

Women	B:C0043210
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	B:C0002844
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	B:C0023516
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	B:C0027950
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	B:C3639411
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	B:C0043210
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	B:C0002844
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	B:C2825077
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	B:C0020268
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	B:C0150312
or	O
not	O
of	O
hyperandrogenemia	O
.	O

Women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≤	O
25	O
kg	O
/m2	O
have	O
significant	O
differences	O
in	O
androgens	O
,	O
white	O
blood	I:C0023516
cells	I:C0023516
,	O
neutrophils	O
and	O
HOMA	O
-	I:C3639411
IR	I:C3639411
and	O
women	O
with	O
body	O
mass	I:C1305855
index	I:C1305855
≥	O
25	O
kg	O
/m2	O
in	O
androgens	O
,	O
thyroid	O
-	I:C2825077
stimulating	I:C2825077
hormone	I:C2825077
and	O
cortisol	O
according	O
to	O
the	O
presence	O
or	O
not	O
of	O
hyperandrogenemia	B:C1299574
.	O

